17-44172267-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000293414.6(ASB16):c.523G>A(p.Glu175Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000353 in 1,613,678 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E175D) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000293414.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB16 | NM_080863.5 | c.523G>A | p.Glu175Lys | missense_variant | 2/5 | ENST00000293414.6 | NP_543139.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB16 | ENST00000293414.6 | c.523G>A | p.Glu175Lys | missense_variant | 2/5 | 1 | NM_080863.5 | ENSP00000293414 | P1 | |
ASB16 | ENST00000589618.1 | c.523G>A | p.Glu175Lys | missense_variant, NMD_transcript_variant | 2/5 | 1 | ENSP00000466033 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152202Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250670Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135622
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727062
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.523G>A (p.E175K) alteration is located in exon 2 (coding exon 2) of the ASB16 gene. This alteration results from a G to A substitution at nucleotide position 523, causing the glutamic acid (E) at amino acid position 175 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at